Clinical Comparison of Two Daily Disposable Toric Soft Contact Lenses
NCT ID: NCT05483127
Last Updated: 2023-11-02
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
153 participants
INTERVENTIONAL
2022-09-13
2022-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Comparison of 2 Daily Disposable Toric Soft Contact Lenses
NCT05039112
Clinical Performance of Two Daily Disposable Toric Soft Contact Lenses
NCT04908488
Clinical Comparison of Two Daily Disposable Contact Lenses - Pilot Study 3
NCT04942925
Clinical Comparison of Toric Contact Lenses Fit Characteristics
NCT05805345
Clinical Performance of Two Daily Disposable Soft Contact Lenses
NCT05138783
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
P1fA, then MDT
Verofilcon A toric soft contact lenses worn first, followed by stenfilcon A toric soft contact lenses, as randomized. Each study lens type will be worn for 8 (-0/+3) days for at least 10 hours per day. Lenses will be removed nightly and disposed of after a single use.
Verofilcon A toric soft contact lenses
Soft contact lenses for optical correction of ametropia and astigmatism
Stenfilcon A toric soft contact lenses
Soft contact lenses for optical correction of ametropia and astigmatism
MDT, then P1fA
Stenfilcon A toric soft contact lenses worn first, followed by verofilcon A toric soft contact lenses, as randomized. Each study lens type will be worn for 8 (-0/+3) days for at least 10 hours per day. Lenses will be removed nightly and disposed of after a single use.
Verofilcon A toric soft contact lenses
Soft contact lenses for optical correction of ametropia and astigmatism
Stenfilcon A toric soft contact lenses
Soft contact lenses for optical correction of ametropia and astigmatism
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Verofilcon A toric soft contact lenses
Soft contact lenses for optical correction of ametropia and astigmatism
Stenfilcon A toric soft contact lenses
Soft contact lenses for optical correction of ametropia and astigmatism
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to wear contact lenses within a range of sphere \& cylinder power and axes.
* Willing to NOT use rewetting/lubricating drops at any time during the study.
Exclusion Criteria
* Monovision and multifocal lens wearers.
* Participation of the subject in a clinical trial within the previous 30 days or currently enrolled in any clinical trial.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sr. Clinical Trial Lead, Vision Care
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kurata Eyecare Center
Los Angeles, California, United States
Sabal Eye Care
Longwood, Florida, United States
Drs. Giedd, P.A.
Maitland, Florida, United States
Vision Health Institute
Orlando, Florida, United States
Franklin Park Eye Center
Franklin Park, Illinois, United States
Kannarr Eye Care
Pittsburg, Kansas, United States
Heart of America Eye Care, P.A.
Shawnee Mission, Kansas, United States
Wesley Optometric Consulting
Medina, Minnesota, United States
ProCare Vision Center
Granville, Ohio, United States
West Bay Eye Associates
Warwick, Rhode Island, United States
Optometry Group, PLLC
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLA306-P002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.